<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36695924</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Hydroxychloroquine: is there a role in long COVID?</ArticleTitle><Pagination><StartPage>977</StartPage><EndPage>978</EndPage><MedlinePgn>977-978</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06514-x</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Samuel S Y</ForeName><Initials>SSY</Initials><Identifier Source="ORCID">0000-0002-1013-7364</Identifier><AffiliationInfo><Affiliation>Rheumatology, Allery and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Chuanhui</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3222-7168</Identifier><AffiliationInfo><Affiliation>Rheumatology, Allery and Immunology, Tan Tock Seng Hospital, Singapore, Singapore. xuchuanhui2008@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="Y">Antimalarials</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36695924</ArticleId><ArticleId IdType="pmc">PMC9874177</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06514-x</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06514-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen C, et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth PH, Gadebusch-Bondio M. The contested meaning of "long COVID" - patients, doctors, and the politics of subjective evidence. Soc Sci Med. 2022;292:114619. doi: 10.1016/j.socscimed.2021.114619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2021.114619</ArticleId><ArticleId IdType="pmc">PMC8629766</ArticleId><ArticleId IdType="pubmed">34906823</ArticleId></ArticleIdList></Reference><Reference><Citation>Self WH, et al. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA. 2020;324(21):2165&#x2013;2176. doi: 10.1001/jama.2020.22240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22240</ArticleId><ArticleId IdType="pmc">PMC7653542</ArticleId><ArticleId IdType="pubmed">33165621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J (2022) Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 132(15). 10.1172/JCI161167</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Udupa A, et al. Hydroxychloroquine and COVID-19: a rheumatologist&#x2019;s take on the lessons learned. Curr Allergy Asthma Rep. 2021;21(1):5. doi: 10.1007/s11882-020-00983-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-020-00983-9</ArticleId><ArticleId IdType="pmc">PMC7818062</ArticleId><ArticleId IdType="pubmed">33475900</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrezenmeier E, D&#xf6;rner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155&#x2013;166. doi: 10.1038/s41584-020-0372-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0372-x</ArticleId><ArticleId IdType="pubmed">32034323</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, et al. Association of higher hydroxychloroquine blood levels with reduced thrombosis risk in systemic lupus erythematosus. Arthritis Rheum. 2021;73(6):997&#x2013;1004. doi: 10.1002/art.41621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41621</ArticleId><ArticleId IdType="pmc">PMC8169526</ArticleId><ArticleId IdType="pubmed">33403833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>